Reaching for the BRAF Ring
Answer to Melanoma Riddle: Not One, but Many Diseases
By Randy Osborne
Monday, May 24, 2010
As the industry braces for an onslaught of data from the American Society of Clinical Oncology meeting next week in Chicago, debate continues about the chances that an approvable therapy will emerge for one of the deadlier, more challenging cancers - melanoma.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.